Literature DB >> 28868167

Comparing the Effects of Combined General/Epidural Anaesthesia and General Anaesthesia on Serum Cytokine Levels in Radical Cystectomy.

Meltem Savran Karadeniz1, Orkhan Mammadov1, Hayriye Şentürk Çiftci2, Sebahat Akgül Usta2, Kamil Pembeci1.   

Abstract

OBJECTIVE: Surgical stress combined with general anaesthesia (GA) suppresses the immune system and leads to cancer cell growth and premature metastasis in major oncological interventions. Epidural analgesia decreases the need for inhalation agents and opioids during surgery by suppressing sympathetic and neuroendocrine responses in the postoperative period. This study aimed to compare the effects of combined general/epidural anaesthesia (GEA)+patient-controlled epidural analgesia (PCEA) and GA+IV patient-controlled analgesia (PCA) on serum tumour necrosis factor-alpha TNF-α), interleukin-1 beta (IL-1β) and interferon-gamma (IFN-γ) levels in patients undergoing radical cystectomy.
METHODS: Sixty-five patients were enrolled in this prospective study. Patients were randomly enrolled to the GEA group, i.e., combined GEA+ PCEA (0.1% bupivacaine+1 μg mL-1 fentanyl), and the GA group, namely combined GA+IV PCA (0.03 mg mL-1 morphine). To evaluate the cytokine response, blood samples were collected at preoperative, postoperative 1st and 24th hours.
RESULTS: There was no statistically significant difference in serum TNF-α, IL-1β and IFN-γ levels between groups GA and GEA at preoperative and postoperative 1st hour and 24th hour. Total remifentanil consumption was significantly lower and length of hospital stay was significantly shorter in the GEA group than in the GA group (p<0.05).
CONCLUSION: There is no difference between two anaesthesia methods in terms of serum cytokine levels; however, combined GEA+PCEA technique appeared to be superior to GA+IV PCA because of lower intraoperative narcotic analgesic consumption and shorter hospital stay.

Entities:  

Keywords:  Radical cystectomy; cytokine; epidural anaesthesia; immune function

Year:  2017        PMID: 28868167      PMCID: PMC5579213          DOI: 10.5152/TJAR.2017.13285

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


  27 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  Anesthesia in patients with cancer disorders.

Authors:  Shin Kurosawa
Journal:  Curr Opin Anaesthesiol       Date:  2012-06       Impact factor: 2.706

3.  Surgical and not analgesic technique affects postoperative inflammation following colorectal cancer surgery: a prospective, randomized study.

Authors:  W Siekmann; C Eintrei; A Magnuson; A Sjölander; P Matthiessen; P Myrelid; A Gupta
Journal:  Colorectal Dis       Date:  2017-06       Impact factor: 3.788

4.  The effect of anaesthesia and surgery on plasma cytokine production.

Authors:  S A Helmy; M A Wahby; M El-Nawaway
Journal:  Anaesthesia       Date:  1999-08       Impact factor: 6.955

5.  Plasma levels of interleukin-6 and interleukin-10 are affected by ketorolac as an adjunct to patient-controlled morphine after abdominal hysterectomy.

Authors:  M H Kim; T S Hahm
Journal:  Clin J Pain       Date:  2001-03       Impact factor: 3.442

6.  The effects of epidural anaesthesia and analgesia on natural killer cell cytotoxicity and cytokine response in patients with epithelial ovarian cancer undergoing radical resection.

Authors:  H Dong; Y Zhang; H Xi
Journal:  J Int Med Res       Date:  2012       Impact factor: 1.671

7.  The Impact of Different Anesthesia Methods on Stress Reaction and Immune Function of the Patients with Gastric Cancer during Peri-Operative Period.

Authors:  Jun Zhao; Huiqin Mo
Journal:  J Med Assoc Thai       Date:  2015-06

8.  CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

Authors:  Luigi Laghi; Paolo Bianchi; Elena Miranda; Emanuela Balladore; Veronica Pacetti; Fabio Grizzi; Paola Allavena; Valter Torri; Alessandro Repici; Armando Santoro; Alberto Mantovani; Massimo Roncalli; Alberto Malesci
Journal:  Lancet Oncol       Date:  2009-08-03       Impact factor: 41.316

Review 9.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

10.  Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study.

Authors:  A Buckley; S McQuaid; P Johnson; D J Buggy
Journal:  Br J Anaesth       Date:  2014-07-09       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.